Stay updated on Pembrolizumab and Radiotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no visible changes to the study details or page layout.
    Difference
    0.1%
    Check dated 2026-03-07T06:38:07.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision history updated for study documents: added revision v3.4.2 and removed v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-13T14:43:35.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added document revision tag v3.4.1 and removed v3.4.0; these are metadata updates that do not affect the study details, eligibility criteria, or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:25:05.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    UI text updates include the addition of glossary toggle options (Show glossary / Hide glossary), capitalization changes to QC-related labels ('Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a revision update from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-22T17:55:45.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears at the bottom of the page, replacing v3.3.3, with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T10:23:50.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added a Locations section with California as a study location; removed the California Locations heading. Revision: v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-17T19:46:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Radiotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.